Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00345189 · ClinicalTrials.gov registry record · Phase 1
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors
A Phase 1 study, sponsored by Biogen.
- Completed
- Registry status
- Phase 1
- Development phase
- 70
- Enrollment target
NCT00345189 is a Phase 1 study that has completed, run by Biogen. The registered enrollment target is 70 participants.
The verdict
NCT00345189, a Phase 1 study, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
This is an open-label, multicenter, dose-escalation, safety, pharmacokinetics, and pharmacodynamics study.
Interventions
- DRUG CNF2024
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00345189
The ClinicalTrials.gov registry entry for NCT00345189 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CNF2024 is the first listed.
NCT00345189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00345189 about?
NCT00345189 is a clinical study titled "Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors". This is an open-label, multicenter, dose-escalation, safety, pharmacokinetics, and pharmacodynamics study.
What is the current status of trial NCT00345189?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 70 participants. The study started on 2006-02. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00345189?
The interventions under investigation include: CNF2024 (DRUG).
Who is sponsoring clinical trial NCT00345189?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.